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Abstract
The human gut is populated with hundreds of types of bacteria and fungi. In North
America, both intestinal and mood disorders are prevalent, presenting health problems that
challenge health care professionals and patients alike. A scholarly literature review was
conducted to explore this important relationship.
The investigation of the literature revealed that there is an association between gut health
disorders and mood disorders, mainly anxiety and depression. This is due to bi-directionality
between the brain-gut pathways, meaning that gastrointestinal health may have an effect on
mental health and vice versa.
This connection between gut and mood can have substantial implications for the
treatment of both GI and mental health patients. Probiotics, bacteria that are beneficial to the
body, have grown in popularity as a gut health supplement and may have an effect on the brain.
Studies were conducted to test whether specific gut flora have effects on mood.
There were many differences identified between the gut flora of those with and without
major depressive disorder. Specific bacterium, such as Lactobacillus plantarum P8,
Bifidobacterium longum NCC300, and Lactobacillus rhamnosus HN001; have undergone
randomized, double-blind, placebo-controlled trials and have been found to decrease feelings of
depression as well as anxiety. Different probiotic strains have different effects on the mind, and
these findings may be among the newest avenues of prevention and/or treatment for depression
and anxiety. The next step will be additional research to validate these findings.
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Introduction
Have you or has someone you’ve known suffered from depression and anxiety? Chances
are, we all know someone who has had their life affected by these disorders; and we have all
experienced these feelings on some level. What if the key to unlocking these problems lied
within every one of us -- inside of our gut? The research topic being explored within this paper is
the relationship between gut health and mood disorders. The question of interest is: Does the use
of probiotic supplementation have an effect on feelings of depression?
The connection between gut health and mental health should be of great significance as
approximately 6.7% of adults in the United States suffer from major depressive disorder
(ADAA, 2018). There has been an observed association between gut health disorders and mood
disorders, mainly anxiety and depression, with a higher prevalence in subjects with inflammatory
bowel diseases (IBD) compared to subjects without IBD. At the same time, those who
demonstrate anxiety and depression have an increased likelihood of developing abnormal
gastrointestinal (GI) symptoms. This raises the possibility of bi-directionality between the brain
and the gut, meaning that GI health may have an effect on mental health and vice versa. Due to
the prevalence of both of these issues in North America, this relationship is important to explore
as it can have large implications for the treatment of both GI and mental health patients. For
example, adding psychological therapies to the treatment regime of those with IBD may lower
their risk of disease relapse and reduce need for pharmacological treatment. Probiotics, bacteria
that are beneficial to the body, have grown in popularity as a gut health supplement which may
have an effect on the brain. There is much reason to suspect and explore the relationship between
probiotic supplements and depression.
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Literature Review
The objective of this research was to find evidence that supports the existence of braingut bidirectionality, and evidence that supplementing probiotics has an effect on the brain and
feelings of depression. This review of literature was compiled using multiple peer-reviewed
journals found through the Dominican University of California library databases, including
ScienceDirect and CINAHL. Eight articles were selected to give a holistic view of the brain-gut
pathway and how probiotics affect the brain. The literature review will be divided into three
categories. First, articles that discuss the pathway between the brain and gut. Second, articles that
assess gut flora and how it affects mood. And third, articles in which probiotics are tested to
determine their effects on mental function. Study designs and methods vary between the articles
and will be described throughout the literature review. See the Literature Review Table in
Appendix A for a summary of each article
The Brain-Gut Pathway
The articles chosen for this portion of the literature review contain data that support the
existence of the brain-gut pathway. Gracie, Guthrie, Hamlin, and Ford (2018) are credited IBD
researchers that wanted to answer the question: do mood disorders increase signs and symptoms
of inflammatory bowel disease and vice versa? These researchers conducted a longitudinal study
of 405 patients diagnosed with inflammatory bowel disease or ulcerative colitis. Data was
collected at baseline and again after two years. This included IBD diagnosis, symptoms,
somatization, fecal calprotectin levels (indicative of IBD flare ups), anxiety and depression data,
and hospitalizations for IBD. The researchers used many standardized scales to compare their
data to a control without IBD; and analysis revealed that the brain-gut pathway did, in fact, exist.
Although the study contained a low prevalence of depression, results showed that anxiety was
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associated with the later development of IBD flare-ups; and patients who were diagnosed with
IBD with no anxiety at baseline showed abnormal anxiety later in the study. This was one of the
first studies to prove that the brain and gut interact bidirectionally, and was the inspiration for
this research paper.
The research team led by Kappelman, Long, Martin, Kinneer, and Chen (2013) used an
incredibly large cohort of patients with inflammatory bowel disease to analyze and evaluate the
association between patient-reported outcomes and disease activity. In 2014, this team recruited
10,634 individuals through the Crohn's and Colitis Foundation of America. They performed a
cross-sectional, longitudinal analysis of disease activity indices, patient recorded outcomes, and
disease-specific quality of life instruments. These researchers used the Patient Reported Outcome
Measurement Information System (PROMIS) to compare the data from IBD patients with the
general population. They used other standardized scales such as the Simple Clinical Colitis
Activity Index and the Short IBD Questionnaire to track disease activity for each specific type of
IBD. Compared to the general population, patients with IBD reported more depression, anxiety,
sleep disturbance, and social interaction. All six of the PROMIS domains indicated that
functioning became worse as disease activity increased, and became better as disease activity
decreased. Although this study was specific to IBD patients, the use of such a large sample size
greatly increases the credibility and reliability of the study, making the results more applicable to
the general population.
Both of the articles in this portion of the literature review focus on IBD patients, but the
findings can be taken and applied to the general population. Whether abnormal levels of anxiety
and depression are a result of inflammatory bowel disease itself or simply a secondary byproduct
of intestinal discomfort, it is clear that there is a connection between gut health and mood.
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Gut Flora and Mood
Since it has been established that there is a connection between gut health and mood, it is
natural to delve further into the gut and question what exactly is acting on the brain. Within the
gastrointestinal system lives an abundance of bacterial flora that aid with digestion, communicate
with the immune system, and produce vitamins. In this portion of the literature review, we will
examine different strains of bacteria found in the gut, and their connection with mood.
In the beginning of 2019, a Taiwanese study was published with the aim of identifying
microbiota targets for major depressive disorder and mood-related traits (Chung et al., 2019).
The researchers recruited thirty-six patients with major depressive disorder (MDD) and thirtyseven subjects without MDD. Depression, anxiety, and stress symptoms were obtained in the
initial interview using the Beck Inventories and the Perceived Stress Scale. Then, subjects were
administered a food questionnaire that contained information about six basic food groups, sugar,
and diet supplements. From this the researchers were able to analyze the amount of carbs, fats,
proteins, and fatty acids being consumed by the subjects based on the frequencies in which they
ate certain foods. Within two weeks of the initial interview, stool samples were collected and
microbiota DNA was extracted using phenol-chloroform or the QIAamp DNA Stool Mini Kit.
Although the sample size for this experiment was small, extensive “16S ribosomal RNA gene
sequencing was conducted” (Chung et al., 2019, p. 76).
The results of this study reveal multiple targets for depression. This includes four phyla,
seven families, and twelve genera (Please see Appendix B). At the phylum level, Actinobacteria
was found in higher prevalence within MDD patients than with controls. Within the family level,
Streptococcaceae and Bifidobacteriaceae were abundant in patients with MDD while
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Prevotellaceae was more abundant in the healthy controls. Finally, at the genus level Clostridium
XI, Parabacteroides, Blautia, and Prevotella were found to be associated with MDD. This was
along with Holdemania, Eggerthella, Streptococcus, and Sutterella, which the authors note as a
similar trend from their research.
The findings from this study are unique and groundbreaking for this topic. Although the
data was collected from a small study of people in Taiwan who may have different lifestyles and
dietary habits from people in other parts of the world, the findings are an excellent foundation for
understanding which bacteria affect major depression.
In 2017, a large group of Italian researchers led by Guida performed clinical studies to
examine the effects of imbalanced microflora on the gut and brains of mice. Their study was
approved by the Animal Ethics Committee of the Università della Campania of Naples. The
control group of mice drank water for fourteen days while the test group drank sterile water
mixed with Ampicillin, Streptomycin, and Clindamycin (ASC). The mice underwent a multitude
of tests to determine depressive-like behavior, motor coordination, muscle strength, recognition
memory, working memory, nociceptive pain, and sociability. A Western blot analysis was done
on brain tissue and samples were collected from each mouse for microbiota analysis and
inflammatory mediator evaluation.
Analysis of the data shows that the administration of antibiotics to perturb natural gut
microbiota leads to “depressive-like behaviour and impaired social activity associated with
biochemical and functional changes in the hippocampus” (Guida et al., 2017, p. 240). The
consumption of the ASC mixture created a floral imbalance with a loss of bacterial diversity.
This increased the presence of Proteobacteria and Actinobacteria in the gut which the authors
believe led to hippocampal rearrangement and depressive behavior. Although this study was
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done on mice, this is the first step to understanding how bacteria can be affecting the human
brain and how this relates to depression.
In both of the studies mentioned, the findings indicate that the microbiota of subjects
experiencing depression differ from subjects without depression. Actinobacteria was
significantly more prevalent in humans with major depressive syndrome as well as mice with
depressive behaviour. Of course, more research can be conducted in this area, specifically
targeting Actinobacteria or some of the other bacteria correlated with depression. However, both
of these studies provide a clear understanding that the intestinal flora of depressed subjects are
dysbiotic compared to non-depressed subjects. From this information one can now ask: what if
there was a way to treat this?
Using Probiotics As Treatment
The following articles involve trials using probiotic supplements. The use of probiotics is
growing in popularity as a potential future medical treatment and as a daily health supplement.
There is still much to learn about different strains of bacteria and what effects each one has on
the brain. The following articles contain recent experiments attempting to learn more about them.
Lew and his team conducted randomized, double-blind, placebo-controlled trials using
Lactobacillus plantarum P8 (2018). The goal of the experiment was to investigate the effects of
probiotics on the alleviation of stress in stressed adults. Subjects were tested for psychological
distress using the aforementioned Perceived Stress Scale questionnaire, along with the
Depression, Anxiety, and Stress Scale (DASS-42), every four weeks. Memory and cognitive
functions were tested at baseline and at the end of the twelve week study. Blood samples were
also collected at these times to analyze cortisol, cytokines, and full blood count. 132 subjects
were originally recruited for the study but only 103 fully complied until the end. By the end of
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the study, most of the effects of treatments (P8 and placebo) were insignificantly different from
one another. However, even though both treatments reduced stress levels from “moderate” at
baseline to “normal” at week 12; during week 4, 8, and 12 the P8 group had much lower stress
than the control. Closer analysis of the DASS-42 over this time period attributes this to reduction
of “touchiness”, reduced irritation, increased calmness, and increased tolerance against
interruptions. This goes to show that L. plantarum P8 may have a potential future as an
anxiolytic supplement.
In Stress matters: Randomized controlled trial on the effect of probiotics on
neurocognition, the team set out to investigate the effects of a multispecies probiotic on the
neurocognitive measures of emotion (Papalini et al., 2019). They wanted to test whether
probiotics could be used to buffer against the effects of stress on memory. This was a
randomized, double blind, placebo-controlled trial that utilized fifty-eight healthy patients. Each
participant was assessed before treatment and again four weeks later. During these assessments
they performed a working memory test and received an MRI measurement. Some of the tests
included the emotional face-matching paradigm which tested for emotional reactivity by
choosing words to match pictures of faces, the color-word stroop paradigm where subjects were
to choose the color of the word ink while ignoring what the word says, and the digit span test
where subjects had to repeat numbers forwards or backwards. During the four week period
subjects were instructed to take the probiotic every day.
The results of the questionnaires and MRIs did not appear to be different between the
probiotic and placebo group. There was, however, a difference in stress-induced working
memory between the groups as the probiotic groups had increased performance on their second
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stress-induced backward digit span performance. These results indicated that the group taking
probiotics had developed a larger buffer against the negative effects of stress on their memory.
Pinto Sanchez and her team conducted research on the probiotic Bifidobacterium longum
NCC3001 to evaluate its effects on anxiety and depression for patients with irritable bowel
syndrome (2017). This study was mentioned multiple times throughout other research and was
used as a guiding framework for other probiotic studies. Data was collected from forty-four IBS
patients at baseline, six weeks, and ten weeks. To qualify, the subjects needed a diagnosis of
IBS, needed to be experiencing diarrhea or mixed-stool patterns, and had to have anxiety and/or
depression. Anxiety and depression were analyzed by the Hospital Anxiety and Depression
Scale. Blood, stool, and urine samples were collected to test for inflammatory markers and
microbiota profiles. MRIs were used to assess brain activity.
After six weeks, the patients in the B. longum group had decreased depression scores
compared to the placebo group. There was no changes found for patients with anxiety.
Sensitivity analysis was used to understand the relationship between B. longum and depression
and the theme was that lower depression was more likely to occur with those who felt adequate
relief from IBS symptoms. MRIs showed that the probiotic group showed reduced engagement
in the amygdala, frontal, and temporal cortices in response to fear stimuli. There was also
heightened engagement of the occipital regions in response to fear. With these results, the
authors drew the conclusion that Bifidobacterium longum NCC3001 decreased depression
scores, but not anxiety scores. They go on to discuss how depression and anxiety are related to
amygdala hyperactivity but both SSRIs and B. longum were able to benefit the patient by
decreasing its activity. This goes to show how probiotics may be able to take a stand in the world
of antidepressants.
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The final article to be reviewed is Effect of Lactobacillus rhamnosus HN001 in
Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind
Placebo-controlled Trial (Slykerman et al., 2017). These trials were conducted in order to
evaluate the effect of the bacteria Lactobacillus rhamnosus HN001 when administered during
pregnancy. The team specifically wanted to evaluate the effects of the bacteria on maternal
anxiety and depression during the postpartum time period. This study received approval from the
New Zealand Multi Regional Ethics Committee and was deemed safe for pregnancy. 423 women
were recruited for this study and were randomly split into a HN001 group and a placebo group.
The mothers were interviewed at 14-16 weeks gestation as their baseline. They received the
probiotic or placebo from the initial interview all the way until six months postpartum if
breastfeeding. The Edinburgh Postnatal Depression Scale and State Trait Anxiety Inventory (6
item) were used to help mothers describe their psychological wellbeing from when their child
was one to two months old. This was done at six or twelve months postpartum.
At the trials’ conclusion, 380 participants completed the study. Eleven of the mothers
completed the questionnaires at the six month visit and 112 completed them at the twelve month
visit. Mothers who received probiotic treatment reported significantly lower depression and
anxiety scores than the placebo group. These scores tended to increase the longer that the mother
took to complete the questionnaire. The researchers believe that this is because many mothers
expect to be tired during their first year of motherhood and do not realize that they may be
depressed. It may be hindsight that allows the mothers to realize how depressed and anxious they
were feeling in the first two months postpartum. The number of women who reported clinically
significant depression above the standard cut-off point did not differ between the HN001 group
and the placebo group. However, women receiving the HN001 treatment were significantly less
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likely to have anxiety above the cut-off point. This study is one of the first of its kind as it studies
the effects of probiotics on pregnant women and postpartum depression. This study could have
been more accurate if they had collected questionnaire data from mothers all at the same time, or
if they administered the questionnaires to each mother twice. This study has great implications
for treatment of postpartum depression and the future of antidepressants.
Literature Review Conclusion
Satisfactory evidence was found on the primary question of interest, “does the use of
probiotic supplementation have an effect on feelings of depression?” According to the research,
the use of different probiotics can have multiple different effects on feelings of depression
including relief of stress, increased calmness, reduced irritation, improved working memory
under stress, and reduced amygdala activity. In addition, certain strains of probiotics also have an
effect on anxiety and possibly IBD flare ups. Lactobacillus plantarum P8, Bifidobacterium
longum NCC300, and Lactobacillus rhamnosus HN001 are three specific probiotic strains that
have demonstrated effects on depression and anxiety.
The greatest limitation that I have found within the studies is the small sample size within
all except Kappelman and Lew’s studies. Data is not as reliable within such small samples, but
because this research is so new it is an acceptable framework. All of the data collected from each
team was located within a specific geographic radius. This can be considered a limitation
because the dietary habits and lifestyle elements of different regions can have an effect on the
microbiota that form in their subject’s studies. This is a consideration to keep in mind while
forming future experiments and studies if one is hoping to focus in on a certain group of people.
Although this research is paving a new route for medical treatments, I do not believe it is
worthy of guiding standard practice quite yet. With the introduction of new bacteria to people’s
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bodies can come new risks and adverse effects. While many practitioners may agree that
probiotics are a safe dietary supplement, more research needs to be done before it can be
recommended as an alternative to SSRIs. There is no proof that probiotics can cure depression or
that they work better than traditional antidepressants, but it may be worthy of mentioning for
patients newly diagnosed with depression. Or even to neurotypical people who may be feeling
some of “the blues.” I believe the research is worthy of guiding future experiments on the topic.
A gap that I have identified within this research is more specified trials to determine
which probiotic strain would be the absolute best for decreasing depression. This gap is not
surprising considering how novel the topic is, and within the next decade there are bound to be
many more studies revealing which probiotics work the best.
Proposal for Further Study
The gap that I have identified within my research are a lack of studies specifically on the
probiotics that have been identified for having effects on depression. By doing further studies on
these probiotics, such as Lactobacillus plantarum P8, Bifidobacterium longum NCC300, and
Lactobacillus rhamnosus HN001, we can determine whether certain strains can be used as
antidepressant therapy. The research study that I would like to propose is a double-blind,
randomized, placebo-controlled clinical trial comparing the effects of specific probiotics on
feelings of depression. The primary research question is: Which probiotic decreases symptoms of
depression in the fastest and most significant way - Bifidobacterium longum NCC300,
Lactobacillus plantarum P8, or both?
As stated in the review of literature, Bifidobacterium longum NCC300 was correlated
with decreased depression. This may be linked to the fact that the probiotic decreases amygdala
activity, which controls the autonomic nervous system and feelings of fear. Selective serotonin
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reuptake inhibitors (SSRIs) are similar to NCC300 in this way. This could imply that higher
doses of NCC300, or doses of NCC300 combined with other elements, could be a competitor
with SSRIs for the treatment of depression. In the study by Lew, Lactobacillus plantarum P8
was not being specifically tested for its effect on depression, but it was correlated with “the
alleviation of selected stress, anxiety, memory and cognitive symptoms in stressed adults”
(2018). All of these factors play a role in clinical depression, so it is not unreasonable to
hypothesize that P8 could have antidepressive effects. For this proposed study, research should
be conducted to determine the efficacy of specific, commonly-used SSRIs. Standardized scales
should be identified so the efficacy of NCC300 and P8 can be compared. By doing this, these
probiotics and SSRIs can be compared to see whether they have similar effects on the feelings of
depression.
The primary aim of this quantitative research is to investigate the effects of
Bifidobacterium longum NCC300, Lactobacillus plantarum P8, and the two combined on
feelings of depression. Another aim of this study is to compare data collected about the efficacy
of NCC300 and P8 as antidepressants with the efficacy of commonly used SSRIs such as Celexa,
Lexapro, Prozac, and Zoloft.
This study would absolutely be cleared by an institutional review board to ensure that
subjects are protected from harm. The Dominican University of California has an Institutional
Review Board that would be able to do this, but due to the nature of the experiment, extra
institutional reviews would be beneficial. With the use of human subjects there is always a risk
of bringing harm to the subject. Because this study involves the supplementation of bacteria,
extra precautions and screening must occur to ensure that no adverse reactions will come to the
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patient, especially those with comorbidities. Before taking any part in the study, all subjects will
need to be educated on what the study will entail and sign a consent form to participate.
The population of this study will be patients age 18-65 who have been diagnosed with
depression. Inclusion criteria will be a diagnosis of depression without any current
pharmaceutical treatments for mental health and the ability to carry out the full experiment.
Exclusion criteria would include current SSRI treatment, current antibiotic therapy, recreational
drug use, body mass index that is severely out of the healthy range, severe medical illnesses, or
mental illness that interferes with the subject’s ability to participate or understand the study. For
this particular study, purposive sampling can be used and subjects can be recruited through
psychologists, therapists, and psychiatrists offices. By doing this, we would be finding
participants who fit the specific criteria without having to sort through and screen every applicant
for their mental health history. From here, the applicants who have passed the screening can be
randomized. My proposed sample size would be at least 500 participants. This sample size was
chosen to account for people dropping out of the study with the intention of having at least 100
participants in the placebo-controlled group, 100 in the Bifidobacterium longum NCC300 group,
100 in the Lactobacillus plantarum P8 group, and 100 in the combination group. Subjects would
be randomized after the screening and assigned different identification numbers every time they
were assessed.
After screening is done and consent is obtained, the initial baseline interview should be
conducted. This should include the subjects’ demographics, diagnoses, current medications, and
feelings of anxiety and depression based on the DASS-42 and BDI-II. The Depression, Anxiety
and Stress Scale (DASS-42) uses a 42 item questionnaire comprised of three sub-scales. Each
scale contains 14 items that assess symptoms such as dysphoria, hopelessness, self-deprecation,
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loss of interests, autonomic arousal, subjective experiences of anxiety, relaxing difficulties,
irritability, and impatience. This standardized scale is a useful tool because it is used in other
health care settings and controls have been established. For the purposes of this experiment, it
will be easier to compare subjects’ results with the results from other studies. Although the focus
of the study is depression, it is not uncommon to find that stress, depression, and anxiety go hand
in hand and influence one another. Using the DASS-42 provides holistic information about the
subjects’ depression and mental state. The Beck Depression Inventory II is a standardized scale
that measures severity of depressive by allowing subjects to rate their feelings on a 1-4 scale
depending on severity (Please see Appendix C). This includes feelings of sadness, guilt,
hopelessness, anhedonia, suicide, crying, agitation, loss of appetite, and more. By using this
second questionnaire we can analyze more specified data regarding depression.
Once the initial interview has been conducted, subjects should receive random numbers
assigning them to the control group, the Bifidobacterium longum NCC300 group, the
Lactobacillus plantarum P8 group, or the combination group. Instructions should be given on
how and when to ingest the probiotic. Subjects should be instructed to ingest the probiotic
powder at approximately the same time every morning. The two questionnaires should be
repeated after six weeks and again after twelve weeks. By doing this, there should be enough
longitudinal data to be able to identify trends and a comparative analysis.
In order to analyze the data from the four groups; NCC300, P8, combination, and
placebo; a one-way analysis of variance (ANOVA) should be performed. This form of analysis
can be used to determine whether there are statistically significant differences between the four
groups. Following this analysis, depression scores can be compared and contrasted with one
another along with previous data collected about SSRIs.
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Theoretical Framework
This framework for my proposed study comes from evidence-based physiology. Studies
have demonstrated that there is a brain-gut pathway that is affected by the flora within the
gastrointestinal system. Clinical trials concluded that a change in the microbiota of the gut could
lead to alterations in mood such as “depressive-like behaviour and impaired social activity
associated with biochemical and functional changes in the hippocampus” (Guida et al., 2017, p.
240). Studies conducted specifically about probiotic supplements have indicated a correlation
between probiotics and decreased feelings of depression, anxiety, stress, and related symptoms.
By understanding the quantitative data behind these studies we are able to delve deeper into
these probiotics to find whether or not they can be used as antidepressant treatment. Without the
research that preceded this proposal, there would not be a reason to suspect that probiotics would
have anything to do with clinical depression.
Conclusion
Throughout the research, satisfactory evidence was found and the primary question of
interest, “does the use of probiotic supplementation have an effect on feelings of depression?”
was answered. Probiotics work on the human body when they are digested, releasing chemicals
that are absorbed in the gastrointestinal tracts and work on the human brain. The effects of these
bacteria can include relief of depressive symptoms along with relief from stress and anxiety.
Lactobacillus plantarum P8, Bifidobacterium longum NCC300, and Lactobacillus rhamnosus
HN001 are three specific probiotic strains that have demonstrated effects on depression and
anxiety. Findings show that different probiotics have different effects on the mind, which is why
much more research should be done on this topic.
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Using this information, health care professionals can develop new ways of treating
depression and anxiety. When a patient is newly diagnosed with depression, the use of therapy
and probiotics could be the first plan of treatment before switching to pharmaceutical drugs like
selective serotonin reuptake inhibitors. Or perhaps probiotics will be so well-studied that they
become the more natural solution to mental health crises and replace pharmaceuticals as the
standard of care altogether.
My proposed research should be one of the first stepping stones in learning whether
probiotics can be used as antidepressants. Before probiotics can be considered as a formal
treatment, much more research needs to be done to explore which bacteria have a negative effect
on depression. Researchers need to narrow down on which strains are the most beneficial for
treatment and do titration studies to determine the best dosage for patients. My study will help to
narrow down and evaluate whether Bifidobacterium longum NCC300, Lactobacillus plantarum
P8, or a combination of these would even be a consideration for further studies. From there,
these will need to be evaluated for adverse effects, contraindications, and any drug interactions.
With time, and more research, there is much hope for the future of probiotics and the treatment
of patients with depression.
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ulcerative colitis
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designn
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patients with
inflammatory bowel
disease.
-anxiety associated
with development
of flare ups
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identified controls
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collect a fecal
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provides more
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recorded outcomes
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-IBD patients
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fatigue, sleep
disturbance, pain
interference, and
had less social
satisfaction than
patients without
IBD.
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undergone prior
colectomies have
reported better
outcomes than UC
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-very large sample
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information
-purposive
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specific source
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data
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questionnaires that
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other studies

-pain interference
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-placebo-controlled
study
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were used (55 with
independent
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-L. Plantarum P8
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and anxiety
symptoms via anti
inflammatory
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cognitive abilities.
-P8 exterts different
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-double blind and
place control
improve validity
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-Study analyzes
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applicable.
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on the effects of
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-This study
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of Bifodobacterium
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patients with IBS

-44 adults with IBS
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-randomized

-double-blind,
placebo controlled
study
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-longitudinal
-history taking,
assessment

-probiotic BL
reduces depression
but not anxiety
scores, increases
quality of life for
patients with IBS
-indications that this
probiotic reduces
limbic reactivity

-using purposive
sampling for this
study was useful in
studying a specific
group of people and
targeting specific
variables
-longitudinal study
provides more
holistic sets of data
-rich data was
collected on
demographics and
brain activation
patterns

-small sample size
was used
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Slykerman, R. F., Hood, F.,
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Murphy, R., … Mitchell, E.
A. (2017). Research Paper:
Effect of Lactobacillus
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Evaluate the effect
of the bacteria
Lactobacillus
rhamnosus HN001
when given in
pregnancy. Also to
evaluate its effects
on maternal
depression and
anxiety postpartum.

-423 women at 1416 weeks gestation
-randomized

-double-blind
placebo-controlled
trials

8

-interviews at
baseline
-questionnaires
when children were
aged 6 and 12
months

-mothers in the
probiotic group
reported lower
depression and
anxiety scores.

-novel study
because the subjects
are pregnant women
-large sample
-randomized,
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placebo-controlled
to boost reliability
of information

-the screening tools
used in this study
were not made to be
asked about the
past. Since the
mothers were
reporting their
feelings of anxiety
and depression in
retrospect, this may
have caused bias
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Microbiota targets in patients with major depressive disorder and healthy controls. Adapted by Chung, et al. (2019, Section 3.2)
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